Compound 338
Identifiers
- Canonical SMILES:
CC(C)(C)C[C@H]1N[C@H]([C@H](c2cccc(Cl)c2F)[C@]11C(=O)Nc2cc(Cl)ccc12)C(=O)NCC[C@H](O)CO
- IUPAC name:
(2'R,3S,3'S,5'R)-6-chloro-3'-(3-chloro-2-fluorophenyl)-N-[(3S)-3,4-dihydroxybutyl]-5'-(2,2-dimethylpropyl)-2-oxospiro[1H-indole-3,4'-pyrrolidine]-2'-carboxamide
- InChi:
InChI=1S/C27H32Cl2FN3O4/c1-26(2,3)12-20-27(17-8-7-14(28)11-19(17)32-25(27)37)21(16-5-4-6-18(29)22(16)30)23(33-20)24(36)31-10-9-15(35)13-34/h4-8,11,15,20-21,23,33-35H,9-10,12-13H2,1-3H3,(H,31,36)(H,32,37)/t15-,20+,21-,23+,27+/m0/s1
- InChiKey:
FYHKPZFIVNTTHR-VAZCYBCOSA-N
External links
71723061 |
External search
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
2 | 2 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
MDM2-Like / P53 | 9.22 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 551.18 g/mol | |||
HBA | 7 | |||
HBD | 5 | |||
HBA + HBD | 12 | |||
AlogP | 3.41 | |||
TPSA | 110.69 | |||
RB | 8 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 2 | 2 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|---|---|---|---|---|---|---|---|
19928922 | 5 | MDM2 Q00987 |
|
Biochemical assay | Fluorescence Polarization | pIC50 (half maximal inhibitory concentration, -log10) | 7.79 | |
19928922 | 5 | MDM2 Q00987 |
|
Biochemical assay | Fluorescence Polarization | pKi (inhibition constant, -log10) | 9.22 | |
19928922 | 5 | MDM2 Q00987 |
|
Cellular assay | Proliferation assay | SJSA-1 cells | pIC50 (half maximal inhibitory concentration, -log10) | 6.70 |
19928922 | 5 | MDM2 Q00987 |
|
Cellular assay | Proliferation assay | Saos-2 cells | pIC50 (half maximal inhibitory concentration, -log10) | 4.74 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.9583 | SAR-405838 | DB12541 | |
0.7500 | Milademetan | DB15257 | |
0.5694 | Idasanutlin | DB12325 | |
0.5388 | Degarelix | DB06699 | |
0.5258 | SLV-334 | DB15356 | |
0.5185 | Mosapramine | DB13676 | |
0.5174 | Acyline | DB11906 | |
0.5122 | Abarelix | DB00106 | |
0.5100 | Daglutril | DB05796 | |
0.5000 | (3S)-N-(3-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE | DB07090 | |
0.5000 | (3S)-N-(5-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE | DB07222 | |
0.4971 | PF-00446687 | DB12517 | |
0.4948 | OPC-51803 | DB05838 | |
0.4906 | Tifuvirtide | DB05413 | |
0.4897 | OPC-14523 | DB05422 |